5 results  1 of 1 

1 Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
Eun Young Lee, Sena Lee, Semi Rho, Jae-Ouk Kim, Seuk Keun Choi, Young Jin Lee, Joo Young Park, Manki Song, Jae Seung Yang
Clin Exp Vaccine Res.2018;7(2):104-110.   Published online 2018 July 31     DOI: http://dx.doi.org/10.7774/cevr.2018.7.2.104
      
2 Epidemiology, management, and prevention of cholera
In-Gyu Bae
J Korean Med Assoc.2017;60(2):140-146.   Published online 2017 February 21     DOI: http://dx.doi.org/10.5124/jkma.2017.60.2.140
      
3 Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
Young Ok Baik, Seuk Keun Choi, Jae Woo Kim, Jae Seung Yang, Ick Young Kim, Chan Wha Kim, Jang Hee Hong
J Korean Med Sci.2014;29(4):494-501.   Published online 2014 April 1     DOI: http://dx.doi.org/10.3346/jkms.2014.29.4.494
      
4 Vaccines today, vaccines tomorrow: a perspective
Christian Loucq
Clin Exp Vaccine Res.2013;2(1):4-7.   Published online 2013 January 15     DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.4
      
5 Vaccines for Diarrheal Diseases
Su Eun Park
Korean J Pediatr Infect Dis.2009;16(2):115-122.   Published online 2009 December 31     DOI: http://dx.doi.org/10.14776/kjpid.2009.16.2.115
      

 1 of 1